180 related articles for article (PubMed ID: 23228205)
1. The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions.
Hu M; Ye L; Ruge F; Zhi X; Zhang L; Jiang WG
BMC Cancer; 2012 Dec; 12():588. PubMed ID: 23228205
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
3. Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression.
Liu Y; Bunston C; Hodson N; Resaul J; Sun PH; Cai S; Chen G; Gu Y; Satherley LK; Bosanquet DC; Al-Sarireh B; Tian X; Hao C; Jiang WG; Ye L
Int J Oncol; 2017 May; 50(5):1491-1500. PubMed ID: 28393239
[TBL] [Abstract][Full Text] [Related]
4. Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells.
Ye L; Sun PH; Martin TA; Sanders AJ; Mason MD; Jiang WG
Urol Oncol; 2013 Nov; 31(8):1576-83. PubMed ID: 22694938
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of ERCC1, RRM1 and BRCA1 in surgically-treated patients with non-small cell lung cancer.
Pesta M; Kulda V; Fiala O; Safranek J; Topolcan O; Krakorova G; Cerny R; Pesek M
Anticancer Res; 2012 Nov; 32(11):5003-10. PubMed ID: 23155271
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of S100A7 reduces lung squamous cell carcinoma cell growth in vitro and in vivo.
Liu G; Wu Q; Liu G; Song X; Zhang J
Int J Clin Exp Pathol; 2014; 7(11):8279-89. PubMed ID: 25550886
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
8. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
Wei LX; Zhou RS; Xu HF; Wang JY; Yuan MH
Tumour Biol; 2013 Apr; 34(2):941-6. PubMed ID: 23264086
[TBL] [Abstract][Full Text] [Related]
9. Psoriasin is aberrantly expressed in human breast cancer and is related to clinical outcomes.
Jiang WG; Watkins G; Douglas-Jones A; Mansel RE
Int J Oncol; 2004 Jul; 25(1):81-5. PubMed ID: 15201992
[TBL] [Abstract][Full Text] [Related]
10. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer.
Ping W; Jiang WY; Chen WS; Sun W; Fu XN
Asian Pac J Cancer Prev; 2013; 14(6):3613-8. PubMed ID: 23886154
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
12. mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry.
Wang L; Yue W; Zhang L; Zhao X; Wang Y; Xu S
Surg Today; 2012 May; 42(5):419-25. PubMed ID: 22127531
[TBL] [Abstract][Full Text] [Related]
13. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma.
Zhan ZY; Zhong LX; Feng M; Wang JF; Liu DB; Xiong JP
Int J Clin Exp Pathol; 2015; 8(5):5080-8. PubMed ID: 26191202
[TBL] [Abstract][Full Text] [Related]
15. High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer.
Cao X; Tang Z; Huang F; Jin Q; Zhou X; Shi J
Oncotarget; 2017 Feb; 8(8):12812-12819. PubMed ID: 28086212
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of HP1γ is associated with poor prognosis in non-small cell lung cancer cell through promoting cell survival.
Zhou J; Bi H; Zhan P; Chang C; Xu C; Huang X; Yu L; Yao X; Yan J
Tumour Biol; 2014 Oct; 35(10):9777-85. PubMed ID: 24981246
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis.
Zhang S; Wang Y; Dai SD; Wang EH
BMC Cancer; 2011 May; 11():186. PubMed ID: 21599923
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China.
Deng Q; Yang H; Lin Y; Qiu Y; Gu X; He P; Zhao M; Wang H; Xu Y; Lin Y; Jiang J; He J; Zhou JX
Int J Clin Exp Pathol; 2014; 7(12):8312-21. PubMed ID: 25674197
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer.
Zhang Y; Yu JH; Lin XY; Miao Y; Han Y; Fan CF; Dong XJ; Dai SD; Wang EH
Virchows Arch; 2011 Sep; 459(3):255-63. PubMed ID: 21818639
[TBL] [Abstract][Full Text] [Related]
20. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]